Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Qureshi, Asaf A ^a   Tan, Xiaoyu ^b   Reis, Julia C ^a,c   Badr, Mostafa Z ^c   Papasian, Christopher J ^a   Morrison, David C ^a   Qureshi, Nilofer ^a,c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMILORIDE; CHYMOTRYPSIN; COREY LACTONE; CYTOKINE; DELTA TOCOTRIENOL; DEXAMETHASONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTONE; MESSENGER RNA; MEVINOLIN; NITRIC OXIDE; PROTEASOME; PROTEASOME INHIBITOR; QUERCETIN; RIBOFLAVIN; TOCOPHEROL; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; LMP7 PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PSMB10 PROTEIN, MOUSE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; ENZYME INHIBITION; FEMALE; GENE REPRESSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; MOUSE MUTANT; MUSCLE; RABBIT;

MUS; ORYCTOLAGUS CUNICULUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TRANSFORMED; CYSTEINE ENDOPEPTIDASES; CYTOKINES; DOWN-REGULATION; FEMALE; I-KAPPA B PROTEINS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PPAR ALPHA; PROTEASOME ENDOPEPTIDASE COMPLEX; RABBITS; RNA, MESSENGER;

EID: 80053898277     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-177     Document Type: Article

References (28)

1. Impact of nitric oxide on metabolism in health and age-related disease. Knott AB, Bossy-Wetzel E, Diabetes Obesity & Metabolism 2010 12 2 126 133 22006574
2. Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Chen LC, Pace JL, Russell SW, Morrison DC, Infection and Immunity 1996 64 10 4288 4298 8926101 (Pubitemid 26318155)
3. Key Inflammatory signaling pathways are regulated by the proteasome. Shen J, Reis J, Morrison DC, Papasian CJ, Sreekumar R, Kolbert C, Qureshi AA, Vogel SN, Qureshi N, Shock 2006 25 472 484 10.1097/01.shk.0000209554.46704.64 16680012
4. The Proteasome as a LPS-binding protein in macrophages: Toxic lipopolysaccharide activates the proteasome complex. Qureshi N, Perera PY, Splitter G, Morrison DC, Vogel SN, J Immunol 2003 171 1515 1525 12874245
5. In vivo inhibition of lipopolysaccharides-induced lethality and tumor necrosis factor synthesis by Rhodobactor sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Suckerman SH, Qureshi N, Infect Immun 1992 60 2581 2587 1612727
6. A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model. Reis J, Tan X, Yang R, Qureshi AA, Papasian CJ, Vogel SN, Morrison DC, Qureshi N, Innate Immunity 2008 14 5 319 329 10.1177/1753425908096855 18809656
7. Proteasome inhibitor, lactacystin blocks CpG DNA- and peptidoglycan induced inflammatory genes, cytokines and mitogen-activated protein kinases in macrophages. Shen J, Gao JJ, Zhang G, Tan X, Morrison DC, Papasian CJ, Vogel SN, Qureshi N, Shock 2006 25 594 599 10.1097/01.shk.0000209555.46704.2d 16721267 (Pubitemid 44297020)
8. The proteasome: A central regulator of inflammation and macrophage function. Qureshi N, Vogel SN, Way CV III, Papasian CJ, Qureshi AA, Morrison DC, Immunological Research 2005 31 3 243 260 10.1385/IR:31:3:243 (Pubitemid 40628961)
9. Tocotrienols inhibit the lipopolysacharides-induced pro-inflammatory cytokines in macrophages of female mice. Qureshi AA, Reis JC, Papasion CJ, Morrison DC, Qureshi N, Lipids in Health and Diseases 2010 9 143 10.1186/1476-511X-9-143
10. -Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Qureshi AA, Reis JC, Qureshi N, Papasion CJ, Morrison DC, Schaefer DM, Lipids in Health and diseases 2011 10 39 10.1186/1476-511X-10-39
11. Molecular inflammation: underpinnings of ageing and age-related diseases. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leewenburgh C, Ageing Res Rev 2009 8 18 30 10.1016/j.arr.2008.07.002 18692159
12. The flavonoid quercetin inhibits pro-inflammatry cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of NF- system. Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C, Clinical and Vaccine Immunology 2006 13 3 319 328 10.1128/CVI.13.3.319-328.2006 16522772
13. Naturally-occurring NF-B inhibitors. Nam N, Mini-Reviews in Medicinal Chemistry 2006 6 945 951 10.2174/138955706777934937 16918500 (Pubitemid 44194381)
14. Retinoid × receptor heterodimers in the metabolic syndrome. Shulman AI, Mangelsdorf DJ, N Endl J Med 2005 353 6 604 615 10.1056/NEJMra043590 (Pubitemid 41138942)
15. Senescence-associated decline in hepatic peroxisomal enzyme activities with diminished levels of retinoid × receptor alpha, but not peroxisome proliferator-activated receptor alpha. Chao C, Youssef J, Rezaiekhaleigh M, Birnbaum LS, Badr M, Mechanisms of ageing and development 2002 123 1469 1476 10.1016/S0047-6374(02)00086-6 12425954 (Pubitemid 35341155)
16. Isolation and structural identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant and antitumor properties. Qureshi AA, Mo H, Packer L, Peterson DM, J Agr Food Chem 2000 48 3130 3140 10.1021/jf000099t
17. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. Stuehr DJ, Nathan CF, J Exp Med 1989 169 1543 1555 10.1084/jem.169.5.1543 2497225 (Pubitemid 19126814)
18. NF-kappa B activation. Abraham E, Crit Carte Med 2000 28 100 N104 10.1097/00003246-200004001-00012
19. Mechanism of dexamethasone-mediated chemokine down-regulation in mild and severe acute pancreatitis. Yubero S, Ramudo L, Manso MA, Dios ID, Biochimica et Biophysica Acta 2009 1792 1205 1211 19818401
20. Amiloride blockades lipopolysaccharide-induced pro-inflammatory cytokine biosynthesis in an IB/NF-B-dependent mechanism. Evidence for the amplification of an anti-inflammatory pathway in the alveolar epithelium. Haddad JJ, Land SC, Am J Respir Cell Mol Biol 2002 26 114 126 11751211 (Pubitemid 34029828)
21. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Chomczynski P, Saachi N, Ana Biochem 1987 162 156 159 (Pubitemid 17064313)
22. LPS-induced formation of immunoproteasome: TNF- and nitric oxide production are regulated by altered composition of proteasome-active sites. Reis J, Guam XQ, Kisselev AF, Papasian CJ, Qureshi AA, Morrison DC, Van Way CW III, Vogel SN, Qureshi N, Cell Biochemistry and Biophysics 2011 60 77 88 10.1007/s12013-011-9182-8 21455682
23. The immunoproteasome regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages. Reis J, Hassan F, Guam XQ, Shen J, Monaco JJ, Papasian CJ, Qureshi AA, Van Way CW III, Vogel SN, Morrison DC, Qureshi N, Cell Biochemistry and Biophysics 2011 60 119 126 10.1007/s12013-011-9183-7 21455681
24. Macrophage expression of peroxisome proliferator-activated receptor-a reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF, Circulation 2007 116 12 1404 1412 10.1161/CIRCULATIONAHA. 106.684704 17724261 (Pubitemid 47417567)
25. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Bensinger SJ, Tontonoz P, Nature 2008 454 7203 470 477 10.1038/nature07202 18650918
26. Control of peroxisome proliferator-activated receptor fate by the ubiquitin proteasome system. Genini D, Catapano CV, Journal of Receptors & Signal Transduction 2006 26 5-6 679 692 10.1080/10799890600928202 22007291 (Pubitemid 44849912)
27. -Tocotrienol inhibits nuclear-B signaling pathway through inhibition of receptor- interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. Ahn KS, Sethi G, Krishnan K, Aggarwal BB, The J Biol Chem 2007 282 1 809 820 (Pubitemid 47076658)
28. Inhibition versus induction of apoptosis by proteasome inhibitors depend on concentration. Lin kI, Baraban JM, Ratan RR, Cell Death and Differentiation 1998 5 577 583 10.1038/sj.cdd.4400384 10200512 (Pubitemid 28356579)